Skip to main content
. 2021 Jun 23;18(13):6762. doi: 10.3390/ijerph18136762

Table 6.

Change in muscle quality and muscle growth regulators during the intervention.

Variables Variables Group Baseline Post d Univariate
Interaction
2p)
Manova
Interaction
2p)
Mid-Thigh
Muscle Quality
MVIC (N·m) RT 112.4 ± 21.60 123.5 ± 18.87 + 1.09 7.417
(0.271)
CG 97.6 ± 30.94 93.7 ± 25.47 0.25
RMVIC (N·m·kg−1) RT 209.9 ± 32.18 231.8 ± 30.25 + 1.20 7.560
(0.274)
CG 195.4 ± 76.53 186.6 ± 61.29 0.26
TTV (cm2) RT 142.3 ± 17.60 142.5 ± 19.28 0.02 0.168
(0.008)
CG 138.5 ± 20.12 140.2 ± 15.56 0.25
TFV (cm2) RT 62.9 ± 15.43 61.7 ± 15.97 0.19 2.965
(0.129)
7.579 *
(0.752)
CG 60.7 ± 13.00 64.5 ± 9.52 0.53
TMV (cm2) RT 74.8 ± 6.77 76.6 ± 7.48 0.44 4.872 *
(0.196)
CG 72.3 ± 8.86 71.0 ± 9.48 0.71
TSFV (cm2) RT 46.9 ± 17.36 46.3 ± 16.09 0.07 0.585
(0.028)
CG 44.7 ± 10.89 46.4 ± 7.41 0.27
IMAT (cm2) RT 16.0 ± 4.60 15.4 ± 3.15 0.25 7.381 *
(0.270)
CG 16.1 ± 3.90 18.1 ± 3.75 ++ 1.06
Muscle Growth Regulator Follistatin (pg·mL−1) RT 2113.75 ± 409.28 2652.85 ± 704.18 + 0.81 4.960 *
(0.199)
2.476
(0.292)
CG 2241.85 ± 669.91 2255.45 ± 564.02 0.04
GDF-8 (pg·mL−1) RT 2294.43 ± 686.62 2193.11 ± 618.91 0.19 1.494
(0.070)
CG 1616.52 ± 650.70 1784.22 ± 529.69 0.33
GDF-15 (pg·mL−1) RT 902.00 ± 406.93 961.81 ± 355.81 0.43 0.943
(0.045)
CG 831.03 ± 262.84 949.32 ± 326.74 0.83
Activin A (pg·mL−1) RT 399.81 ± 93.59 362.42 ± 76.83 0.45 0.011
(0.001)
CG 340.37 ± 61.61 305.94 ± 53.01 0.90

Values are expressed as mean ± SD, MVIC; maximum voluntary isomeric contraction, RMVIC; relative maximum voluntary isomeric contraction, TTV; thigh cross-sectional area total thigh volume, TFV; thigh fat volume TMV; thigh muscle volume, TSFV; thigh subcutaneous fat volume, IMAT; intramuscular fat, * Significant interaction effect, * p < 0.05, + Significant difference between pre- and post-test, + p < 0.05, ++ p < 0.01, Cohen’s d; small ≥ 0.2, medium ≥ 0.5, large ≥ 0.8, η2p; small ≥ 0.01, medium ≥ 0.06, large ≥ 0.14.